Science, innovation and commitment

Mutation in DOCK11 gene explains rare disorder in immune system regulation

Researchers from the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital participate in an international study, published in the prestigious scientific journal New England Journal of Medicine, which describes for the first time a new disease of the immune system caused by a mutation of the DOCK11 gene.

A study has revealed an association between mental disorders and premature mortality in the Catalan population

A research team from the Parc Sanitari Sant Joan de Déu · Institut de Recerca Sant Joan de Déu analyses the link between experiencing a mental disorder and the risk of premature death in the Catalan population.

New insights into COVID-19 protection in children have revealed the presence of sACE2 in the saliva

The presence of the soluble angiotensin-converting enzyme 2 (sACE2) in saliva could have implications for COVID-19 infection, prevention and control, according to researchers from the Institut de Recerca Sant Joan de Déu and the University of Catalunya. This study has been published in Scientific Reports.

Metformin, key drug in the battle against type 2 Diabetes, reveals its secrets in a new study

Dr. Manuel Vázquez-Carrera, Institut de Recerca Sant Joan de Déu (IRSJD) and professor from the Faculty of Pharmacy and Food Sciences of the University of Barcelona, leads this new study on metformin, one of the most prescribed drugs for treating type 2 diabetes mellitus.


TECSAM | Breakfast & Learn: Mental health and women: challenges in first person

Speaker: Mercè Torrentallé, Alicia Mendo Olmos, Carmen Prieto and Raquel Montllor Linares.


09:00 h

TECSAM | Technology Exploration Day 2023

UPF Barcelona School of Managment



Manel González-Piñero

Headof Innovation at CREB UPC and XarTEC SALUT

"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."

Read more More Interviews